Edition:
Deutschland

Aradigm Corp (ARDM.OQ)

ARDM.OQ on NASDAQ Stock Exchange Capital Market

1.22USD
17 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.22
Open
$1.21
Day's High
$1.22
Day's Low
$1.20
Volume
1,375
Avg. Vol
7,823
52-wk High
$7.26
52-wk Low
$1.04

ARDM.OQ

Chart for ARDM.OQ

About

Aradigm Corporation is a pharmaceutical company focused on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. The Company's lead product candidate is Pulmaquin inhaled ciprofloxacin, which is in Phase III clinical trials. It offers AERx pulmonary drug delivery... (more)

Buy/Sell

Sell Hold Buy
3.00 Mean rating from 1 analysts

Overall

Beta: 1.63
Market Cap(Mil.): $55.61
Shares Outstanding(Mil.): 15.11
Dividend: --
Yield (%): --

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.53%
Rohstoffe -0.35%
Industrie -0.03%
Konjunktur abhängige Waren & Dienstleistungen -0.15%
Konjunktur unabhängige Waren & Dienstleistungen +0.01%
Finanzindustrie +0.08%
Pharma -0.12%
Technologie +0.19%
Telekommunikation +0.13%

Nachrichten aus der Wirtschaft